Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
2.250.000 people have already made a change
Een onderzoek uit 2025 toont aan dat 22% van de gebruikers van GLP-1-receptoragonisten binnen n jaar een voedingstekort ontwikkelt
Some don't notice any change at all
The increase was modest and did not produce clinical events in the trial population, but researchers with pre-existing cardiovascular conditions should factor this into their risk assessment
They help minimize unintended nutrient deficiencies which could compromise bone health, immune function, skin/tissue quality, mood, cognition
The author holds equity interest in RNA Therapeutics Inc, DEI Biopharma Inc, Abyolo, and BioRx Inc, but none of these create any conflict of interest for this paper
US$ 27.03
US$ 26.84
US$ 21.45
US$ 23.45
US$ 20.58
